Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Obesity: Italy’s pioneering legislation should serve as a model for Europe
- Investments in Health and Well-Being for Residents of Labrador
- BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
- Five Million People in U.S. Trained in Mental Health First Aid
- Democratic Lawmakers Question If Trump Is Mystery Recipient of Drug
- American fitness influencer Connor Murphy drowns in Samut Prakan lake
- Raddish Kids Supports Save the Children with Large-Scale Donation Nurturing Healthy Eating Habits
- UC Davis Public Health Sciences earns seven
Browsing: Announces
This is a paid press release. Contact the press release distributor directly with any inquiries.
This is a paid press release. Contact the press release distributor directly with any inquiries.
UPPER EAST SIDE, Manhattan (WABC) –New York City health officials held a town hall on Tuesday night on the Upper East Side to try to calm fears amid a Legionnaires’ outbreak
VANCOUVER, BC, July 7, 2026 /PRNewswire/ – ELSE NUTRITION HOLDINGS INC. (CSE: BABY) (OTCQX: BABYF) (FSE: 0YL) (the “Company”) announces that it has completed the previously announced consolidation of its common shares on the basis of one (1) post-consolidation common share for every ten (10) pre-consolidation common shares. The Company’s common shares will commence trading on…
WASHINGTON, July 7, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to VCA-894A, Vanda’s investigational antisense oligonucleotide therapy for the treatment of Charcot-Marie-Tooth disease, axonal, type 2S (CMT2S), a rare, serious, and progressive inherited neurological disorder. The designation…
WALTHAM, Mass., July 07, 2026 (GLOBE NEWSWIRE) — Kailera Therapeutics, Inc. (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced positive topline data from two additional Phase 3 clinical trials of oral small molecule GLP-1 receptor agonist HRS-7535 (also known as KAI-7535) conducted by Hengrui Pharma: the Phase…
NEW YORK, July 6, 2026 /PRNewswire/ — Nuvation Bio Inc. (“Nuvation Bio”) (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that the underwriters have exercised in full their over-allotment option (the “Greenshoe Exercise”) to purchase an additional $37.5 million aggregate principal amount of its…
CHARLESTON, S.C. (WCIV) —Convenience store chain Parker’s Kitchen has announced a round-up campaign with proceeds going towards Roper St. Francis Healthcare in Charleston
Transaction sharpens company’s focus on AI-driven transformative intelligence for its leading Academia & Government and Intellectual Property segments

